CDC Shortens Pfizer COVID Booster Interval to Five Months. Experts Warn Practice Is Unstudied

Americans who got fully vaccinated with Pfizer-BioNTech COVID shot are now being told to get a third dose sooner, as the U.S. Centers for Disease Control and Prevention (CDC) shortened the recommended interval between the initial inoculation and boosting from six to five months.  

The CDC updated its recommended waiting period for those who completed their primary vaccination series with Pfizer’s shots while leaving the booster interval recommendation for people who received the Johnson & Johnson vaccine (two months) or the Moderna vaccine (six months) unchanged on Tuesday.

The agency that is currently being sued for refusing to publicize the post-licensure COVID vax safety data is also recommending that moderately or severely immunocompromised 5–11-year-old children receive an additional primary dose of the vaccine 28 days after their second shot. At this time, only the Pfizer-BioNTech jab is authorized and recommended for children of that age.

Speaking of the changes, CDC Director Rochelle Walenski assured the public that her agency “will continue to update our recommendations to ensure the best possible protection for the American people” while urging all eligible Americans to get a booster for themselves and their “vulnerable” children.

Walenski also reminded Americans that the U.S. Food and Drug Administration (FDA) has authorized boosters for 12-15 year-olds earlier this week. That is the same FDA that has been aware of the tens of thousands of severe side effects and more than a thousand deaths that have occurred in vaccinated people within the first two and a half months of the Pfizer jab rollout. The regulatory agency is now being taken to court for refusing to expeditiously disclose Pfizer safety data it used to authorize the shot.

Pfizer CEO Albert Bourla, not surprisingly, was pleased with the developments. Commenting on the FDA shortening the waiting period between the second and third doses on Monday, Bourla said that his company “continue[s] to believe that broad use of boosters is essential to preserving a high level of protection against this disease and reducing the rate of hospitalizations” and “will be critical to help us ultimately defeat this pandemic.” Just over a month ago, however, Bourla indicated that after people get triple-vaccinated, they will have to be “re-vaccinated” against COVID on an annual basis, arguing that the virus constantly mutates, and the immunity provided by the vaccines wanes over time. Given the virus is arguably mutating because of the vaccines that do not prevent infection, the boosters endorsed by the federal agencies will make the pandemic infinite.

The news comes as the United States, where 73.3 percent of all eligible citizens have received at least one dose of the shot, and more than a third are boosted, reported a single-day record number of COVID cases, with more than one million new infections on Monday.

President Joe Biden’s top scientific advisor, Dr. Anthony Fauci, signaled on Tuesday that the definition of “fully vaccinated” — or “vaccinated up-do-date,” as he called it — is about to change in the near future.

“We’re using the terminology now ‘keeping your vaccinations up to date,’ rather than what ‘fully vaccinated’ means,” Fauci said during a National Institutes of Health (NIH) lecture. “Right now, optimal protection is with a third shot of an mRNA or a second shot of a J&J.”

The New American has reported that, as of the end of December, numerous countries have shortened COVID booster intervals over Omicron fears.

Not so long ago, even official entities such as the World Health Organization (WHO) and the European Commission (EC) warned against blanket use of COVID booster shots, for which safety and efficacy have not been studied. Furthermore, in the United States, all of the currently available COVID shots for adults have yet to complete clinical trials, with the earliest completion date set for May of 2023.

Non-establishment scientists, such as Dr. Peter McCullough, explained that due to the widespread memory-type antibody response to SARS-CoV-2, the antibodies induced by the COVID vaccines can bring about the destruction of any cell that manufactures the SARS-CoV-2 spike protein, particularly in circulation. Every additional dose will make the spike protein accumulate further in different organs, which could become targets of an autoimmune attack.

That same mechanism was recently described by Dr. Sucharit Bhakdi, who urged people to forgo any additional doses of the vaccines to reduce the risk of autoimmune damage. Along with Dr. Arne Burkhardt, he found that 14 of the 15 vaccinated patients who died had autoimmune damage in different organs.

In the meantime, across the pond, director of the Oxford Vaccine Group and chair of the U.K.’s Committee on Vaccination and Immunization Sir Andrew Pollard spoke against the booster doses for the general population.

“We know that people have strong antibodies for a few months after their third vaccination, but more data is needed to assess whether, when, and how often those who are vulnerable will need additional doses,” Pollard said. “We can’t vaccinate the planet every four to six months. It’s not sustainable or affordable. In the future, we need to target the vulnerable.”

He added that the combination of natural immunity and the immunity gained thanks to the initial doses of the shots are strong enough the protect against Omicron, which is much less severe than the Delta variant, as a growing body of scientific evidence suggests.

Countering Overreach Banner728